Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8744 USD | +0.51% | +4.10% | +37.05% |
04-22 | HeartCore Enterprises Provides AI Capabilities to Heart-Tech Health | MT |
04-22 | Heartcore Enterprises, Inc. Expands Partnership with Heart-Tech Health | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Its low valuation, with P/E ratio at 2.81 and 2.56 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- For the past twelve months, EPS forecast has been revised upwards.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+37.05% | 18.13M | - | ||
+9.17% | 3,042B | C+ | ||
+6.91% | 83.84B | B | ||
+3.74% | 77.3B | B+ | ||
-13.64% | 53.92B | B+ | ||
-24.95% | 47.93B | B- | ||
+25.57% | 47.66B | D+ | ||
+19.54% | 43.81B | D+ | ||
+64.81% | 37.42B | D+ | ||
-14.63% | 25.93B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HTCR Stock
- Ratings HeartCore Enterprises, Inc.